ACN Earnings: Accenture Stock Slips on Dismal Outlook
Market News

ACN Earnings: Accenture Stock Slips on Dismal Outlook

Story Highlights

Accenture shares are under pressure today after the company scaled back its financial outlook for the full year.

Shares of professional services major Accenture (NYSE:ACN) are tanking today after the company announced its second-quarter results and scaled back its financial outlook for the full year. In Q2, revenue contracted marginally by 0.1% year-over-year to $15.8 billion. The figure lagged expectations by $50 million. EPS of $2.77, on the other hand, fared better than estimates by $0.11. Notably, Accenture has clocked new generative AI bookings worth $1.1 billion in the first half of FY2024.

During the second quarter, new bookings stood at $21.6 billion, indicating a year-over-year decline of 2%. While Consulting revenues declined by 3% to $8.02 billion, revenues from managed Services ticked up by 3% to $7.78 billion. Despite an essentially flat top line, the consulting giant managed to increase its operating income by 5% to $2.05 billion.

Separately, Accenture has declared a quarterly cash dividend of $1.29 per share. The ACN dividend is payable on May 15 to investors of record on April 11. For the upcoming quarter, Accenture expects revenue to be in the range of $16.25 billion to $16.85 billion.

Revised Expectations

For the full Fiscal year, Accenture has scaled back its revenue growth expectations to a range of 1% to 3% from the prior outlook of 2% to 5% growth. Adjusted EPS for the year is seen landing between $11.97 and $12.20. It previously estimated adjusted EPS for 2024 in the range of $11.97 to $12.32.

Is ACN Stock a Good Buy?

Today’s price erosion comes after a nearly 50% rally in the company’s share price over the past year. Overall, the Street has a Moderate Buy consensus rating on Accenture alongside an average ACN price target of $402.59. However, analysts’ views on the company could see changes following today’s earnings report.

Read full Disclosure

Related Articles
TheFlyAccenture acquires Allitix, terms not disclosed
TheFlyExane downgrades Accenture to Neutral on slower growth recovery
TheFlyAccenture downgraded to Neutral from Outperform at Exane BNP Paribas
Go Ad-Free with Our App